Sessions at the DIA 2015 51st Annual Meeting will bring together individuals across all disciplines in the discovery, development, and life cycle management of health care products with a goal of fostering innovation that will lead to the development of safe and effective medical products and therapies. The Annual Meeting will be held at the Walter E. Washington Convention Center from June 14 to 18. This year’s program co-chairs are Michael Rosenblatt, MD, Executive Vice President and Chief Medical Officer, Merck & Co., Inc. and Christopher P. Austin, MD, Director, National Center for Advancing Translational Science, National Institutes of Health.
The meeting includes more than 245 educational offerings over 20 tracks on today’s hottest topics surrounding 21st Century Cures, health care applications of cloud computing and disruptive technologies, patient engagement, repurposing of drugs, and social media strategies. For the second year, DIA also will host The Walking Gallery, a patient empowerment movement founded by artist Regina Holliday (June 15, 4-6pm).
“The DIA Annual Meeting is an opportunity for people working across the life sciences to convene in an open and collaborative forum to share views, knowledge and expand upon best practices that can accelerate and transform health care product development,” said Barbara Lopez Kunz, DIA’s global chief executive. “We look forward to bringing together patients and professionals from around the world to engage in rich discussion and provide expertise critical to advancing the future of health care.”
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.
DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, Africa and the Middle East (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan). For more information, visit our website at www.DIAGlobal.org or contact us via Twitter @DrugInfoAssn, LinkedIn or on Facebook.